Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56826 - 56850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	TUBB2A	7280	upregulated	panobinostat results in increased expression of TUBB2A mRNA	6p25.2	A21037
Panobinostat	Approved Investigational	TWIST1	7291	upregulated	panobinostat results in increased expression of TWIST1 mRNA	7p21.1	A21037
Panobinostat	Approved Investigational	UGT8	7368	upregulated	panobinostat results in increased expression of UGT8 mRNA	4q26	A21037
Panobinostat	Approved Investigational	UNC5A	90249	downregulated	panobinostat results in decreased expression of UNC5A mRNA	5q35.2	A21037
Panobinostat	Approved Investigational	UNC5C	8633	upregulated	panobinostat results in increased expression of UNC5C mRNA	4q22.3	A21037
Panobinostat	Approved Investigational	UQCC2	84300	downregulated	panobinostat results in decreased expression of UQCC2 mRNA	6p21.31	A21037
Panobinostat	Approved Investigational	USP28	57646	upregulated	panobinostat results in increased expression of USP28 mRNA	11q23.2	A21037
Panobinostat	Approved Investigational	USP49	25862	downregulated	panobinostat results in decreased expression of USP49 mRNA	6p21.1	A21037
Panobinostat	Approved Investigational	UTF1	8433	upregulated	panobinostat results in increased expression of UTF1 mRNA	10q26.3	A21037
Panobinostat	Approved Investigational	VAMP7	6845	upregulated	panobinostat results in increased expression of VAMP7 mRNA	Xq28 and Yq12	A21037
Panobinostat	Approved Investigational	VAMP8	8673	upregulated	panobinostat results in increased expression of VAMP8 mRNA	2p11.2	A21037
Panobinostat	Approved Investigational	VAPA	9218	downregulated	panobinostat results in decreased expression of VAPA mRNA	18p11.22	A21037
Panobinostat	Approved Investigational	VASH2	79805	upregulated	panobinostat results in increased expression of VASH2 mRNA	1q32.3	A21037
Panobinostat	Approved Investigational	VENTX	27287	upregulated	panobinostat results in increased expression of VENTX mRNA	10q26.3	A21037
Panobinostat	Approved Investigational	VEPH1	79674	upregulated	panobinostat results in increased expression of VEPH1 mRNA	3q25.31-q25.32	A21037
Panobinostat	Approved Investigational	VGLL1	51442	upregulated	panobinostat results in increased expression of VGLL1 mRNA	Xq26.3	A21037
Panobinostat	Approved Investigational	VGLL3	389136	upregulated	panobinostat results in increased expression of VGLL3 mRNA	3p12.1	A21037
Panobinostat	Approved Investigational	WDR72	256764	upregulated	panobinostat results in increased expression of WDR72 mRNA	15q21.3	A21037
Panobinostat	Approved Investigational	WFDC2	10406	upregulated	panobinostat results in increased expression of WFDC2 mRNA	20q13.12	A21037
Panobinostat	Approved Investigational	WNT10B	7480	upregulated	panobinostat results in increased expression of WNT10B mRNA	12q13.12	A21037
Panobinostat	Approved Investigational	WNT3	7473	upregulated	panobinostat results in increased expression of WNT3 mRNA	17q21.31-q21.32	A21037
Panobinostat	Approved Investigational	WNT4	54361	upregulated	panobinostat results in increased expression of WNT4 mRNA	1p36.12	A21037
Panobinostat	Approved Investigational	WNT5A	7474	downregulated	panobinostat results in decreased expression of WNT5A mRNA	3p14.3	A21037
Panobinostat	Approved Investigational	WNT5B	81029	downregulated	panobinostat results in decreased expression of WNT5B mRNA	12p13.33	A21037
Panobinostat	Approved Investigational	WWC1	23286	upregulated	panobinostat results in increased expression of WWC1 mRNA	5q34	A21037

Displaying entries 56826 - 56850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability